Ambu Q4 EBIT jumps 99% to DKK 293 million; Q4 revenue rises 16% to DKK 1.7 billion
Bitget2026/11/05 06:04- Ambu’s EBIT jumped 99% to DKK 293 million in Q4 2025/26.
- Revenue rose 16% to DKK 1.7 billion, while free cash flow before acquisitions climbed 66% to DKK 216 million.
- The acquisition of TIMS Medical expanded its endoscopy offering with hospital integration and workflow technology.
- For 2026/27, Ambu expects organic revenue growth of 9.5–11.5% and an EBIT margin of 13–15%.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cybertruck orders far exceed pre-production capacity, Tesla (TSLA.US) to refund deposits to a large number of customers
Elon Musk stated that Tesla will refund the Cybertruck deposits to a significant number of customers.

Barrick Gold (B.US) Q3 Results Mixed: Benefiting from Gold Price Dividend While Facing Cost Pressures
Barrick Mining (B.US) will release its financial results for the third quarter of 2026 before the U.S. stock market opens on November 9.
Europe Becomes a Safe Haven Amid AI Turbulence! Citi Turns Bullish on European Stocks, Downgrades US Stocks: Low AI Exposure Seen as Key Advantage
Citigroup strategists have downgraded the rating of U.S. stocks and upgraded the rating of European stocks, following the recent market turbulence caused by upheaval in the artificial intelligence industry.

Rumor: Tesla (TSLA.US) and SpaceX (SPCX.US) plan Terafab monthly production of one million wafers, feasibility questioned
According to reports, Tesla (TSLA.US) and SpaceX (SPCX.US) plan to achieve a production capacity of 1 million semiconductor wafers per month at the proposed Terafab factory starting in 2032.
